Delivery Order SPE2DB20D7059-SPE2DB25FQPG0
Award Date 8/29/25
Potential Completion Date 9/2/25
Potential Value $6.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 21, 2025, for the supply of Vyvanse 40 mg capsules (100-count packages) valued at $3,908.42. This non-set-aside, competitively awarded delivery order represents a firm fixed-price contract with an ultimate completion date of August 22, 2025, and will be performed at the vendor's corporate office location in Conshohocken, PA. The award is funded by...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency on August 29, 2025, for the supply of Vyvanse 60 mg capsules (100-count units). The contract was competitively awarded without set-aside designation and carries a ceiling value of $1,065.93, with a firm fixed price structure and an ultimate completion date of September 2, 2025. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,904.90 by the Defense Logistics Agency's Medical Supply Chain on August 12, 2025, for the supply of Vyvanse 30 milligram capsules (100 count). The contract represents a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, and was competitively awarded without set-aside designation. This award falls under...
- The Defense Logistics Agency awarded a $1,269.13 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 70 mg on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,201.18 for 100 capsules of Vyvanse 50 mg on August 22, 2025, with completion scheduled for August 25, 2025. This firm fixed-price, non-set-aside contract will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a purchase order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, which carries a $999.99 billion ceiling...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Vyvanse 20 mg capsules (100-count units) under a firm fixed-price contract valued at $4,808.70. This non-set-aside competitive award represents a child delivery order against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a $2,085.82 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 40 mg on August 28, 2025, with completion expected by August 29, 2025. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order for pharmaceutical supply to support federal medical procurement needs. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 20, 2025, for the supply of Vyvanse 70 mg capsules (100 count) with a contract ceiling value of $2,152.71. This award is a firm fixed-price delivery order with an ultimate completion date of August 21, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,083.09 delivery order for 100 capsules of Vyvanse 30 mg on August 13, 2025, with completion targeted for August 14, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be...
- The Defense Logistics Agency awarded a $13,377.00 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 20 mg on August 20, 2025, with completion targeted for August 21, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's broader pharmaceutical supply relationship with the...